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Abstract
Hirschsprung disease (HSCR) is a congenital disorder characterized by aganglionosis of the distal intestine. To assess the
contribution of copy number variants (CNVs) to HSCR, we analysed the data generated from our previous genome-wide
association study on HSCR patients, whereby we identified NRG1 as a new HSCR susceptibility locus. Analysis of 129 Chinese
patients and 331 ethnically matched controls showed that HSCR patients have a greater burden of rare CNVs
(p= 1.5061025), particularly for those encompassing genes (p= 5.0061026). Our study identified 246 rare-genic CNVs
exclusive to patients. Among those, we detected a NRG3 deletion (p= 1.6461023). Subsequent follow-up (96 additional
patients and 220 controls) on NRG3 revealed 9 deletions (combined p= 3.3661025) and 2 de novo duplications among
patients and two deletions among controls. Importantly, NRG3 is a paralog of NRG1. Stratification of patients by presence/
absence of HSCR–associated syndromes showed that while syndromic–HSCR patients carried significantly longer CNVs than
the non-syndromic or controls (p= 1.5061025), non-syndromic patients were enriched in CNV number when compared to
controls (p= 4.0061026) or the syndromic counterpart. Our results suggest a role for NRG3 in HSCR etiology and provide
insights into the relative contribution of structural variants in both syndromic and non-syndromic HSCR. This would be the
first genome-wide catalog of copy number variants identified in HSCR.
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Introduction
Hirschsprung disease (HSCR, aganglionic megacolon) is a rare,
congenital disorder characterized by the absence of enteric ganglia
along a variable length of the intestine. It can be classified
according to the length of aganglionosis into short segment (S-
HSCR; 80% of the cases), long-segment (L-HSCR; 15%) and total
colonic aganglionosis (TCA; 5%). The incidence of Hirschsprung
disease varies by gender and ethnicity, and is highest among
Asians (2.8/10,000 newborns) [1]. The male:female ratio is <4:1
among S-HSCR patients and <1:1 among L-HSCR patients. The
majority of HSCR patients are isolated (non-syndromic and
sporadic) S-HSCR whose modes of inheritance are primarily
multifactorial.
Since the discovery of the major HSCR gene, receptor tyrosine
kinase (RET; 10q11), a number of rare mutations have been
reported in genes (EDNRB; 13q22, GDNF; 5p13, PHOX2B; 4p13,
SOX10; 22q13, etc) mostly involved in the two interrelated
pathways: RET and endothelin receptor B (EDNRB) signaling
cascade [1]. However, together these mutations are of incomplete
penetrance and account for only 50% of the familial (mostly L-
HSCR, TCA) and up to 20% of the sporadic cases (mostly S-
HSCR), contributing to only a small proportion of the heritability
[2]. On the other hand, common variants in RET and NRG1
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(8p12) were found associated with all sub-phenotypes and
explained a considerably larger variance [3,4]. Still, in spite of
the vast coding sequence (CDS) mutation screening and the
genome-wide association mapping on HSCR patients, a substan-
tial genetic contribution remained elusive.
Copy number variations (CNVs), which represent an important
portion of missing heritability, have recently been highlighted as
significant genetic risk factors in disease pathogenesis, such as
schizophrenia, autism and early-onset obesity [5–7]. Through
these genome-wide CNV analyses, a number of disease-suscepti-
bility genes have been suggested (e.g. SH2B1 in obesity and
NRXN1 in autism and schizophrenia). In fact, CNV discovery has
been essential for uncovering genes/risk factors for a wide range of
diseases, including Hirschsprung disease. The two major HSCR
genes—RET and EDNRB—are indeed the classical examples of
how structural variations assist in mapping the disease-predispos-
ing genes. It is estimated that about 12% of Hirschsprung patients
have structural abnormalities [1]. Among these, trisomy 21
(Down’s syndrome) is the commonest anomalies, involving 2–
10% of the patients [8]. Given this early impact of CNVs on gene
discovery and the non-random association of HSCR with
syndromes, it is highly probable that structural variations
underlain HSCR. Thus far, several studies have attempted to
survey CNVs in the targeted HSCR genes (RET, GDNF, etc) [9–
11], albeit the extent to which CNVs contribute to HSCR is still
largely unknown.
To systematically explore the global contribution of CNVs to
the disease, we performed a genome-wide copy number analysis
based on our previously published SNP genotyping data [3]. By
performing a comprehensive association analysis on the identified
structural variants, we aimed to uncover novel genes conferring
risk to HSCR.
Results
After extensive pre- and post- calling quality control (QC), we
obtained a stringent dataset of 866 CNVs with a median size of
34.39 kb in 129 HSCR cases (excluding chromosome 21 for 8
Down’s syndrome patients) and 1515 CNVs with a median size of
57.90 kb in 331 ethnically matched controls. Apart from the 1.5
fold increase in average CNV count for cases, a higher proportion
of deletions, presumably of larger functional impact, were also
observed in cases (59.36%) over controls (51.68%), which allowed
us to hypothesize that CNVs significantly contribute to the
pathogenesis of HSCR.
To delineate the global impact of CNVs on disease suscepti-
bility, we compared the overall CNV burden in cases relative to
controls, in terms of the estimated CNV size, number of CNVs per
individual (rate of CNV) and number of genes overlapped by
CNVs (gene count).
Greater burden of rare CNVs in HSCR patients
Rare CNVs (present in ,1% of the general population) were
found significantly overrepresented in HSCR cases with a ratio of
1.97 (p=1.5061025; conditional permutation p=4.9761023).
Such difference was not observed for common CNVs, in
accordance with their weak global contribution to diseases [12].
As shown in Table 1, the rate of both rare deletions and
duplications were significantly higher in HSCR patients; further-
more, these CNVs intersected with more genes. The association
was stronger for deletions with a 2.31 fold increase in rate
(p=9.2061025; conditional permutation p=0.017) and with 7.61
times more genes overlapped when compared to controls
(p=5.0061026; conditional permutation p=2.6061025). In
particular, long deletions (.100 kb) were 14 times enriched with
genes in cases when compared to controls (p=4.2561024;
conditional permutation p=2.6161024). This could be partly
explained by the increase in number of CNVs per patient (rate)
(p=0.014; conditional permutation p=0.051) as well as by the
larger size of CNVs (p=0.047; conditional permutation p=0.015)
when compared to controls. Consistently, singleton (single
occurrence) genic deletions were found more abundant in patients.
Recognizing that CNV analysis is more sensitive to outliers and
batch effects, we evaluated if any of these potential factors might
account for the observed CNV burden (Text S1, Table S3, Figures
S2, S3 and S4). For both CNV rate and gene count, the distinctive
overall CNV distribution in HSCR cases (Figure S6) together with
the insignificant association with Affymetrix plates confirmed that
our findings were not attributed to experimental artifacts.
Moreover, the similar level of significance for overrepresentation
achieved by conditional permutation on data quality, as illustrated
by conditional p-value in Table 1, further demonstrated the
robustness of our findings.
Summarizing, HSCR patients have more rare-CNVs and more
genes intersected by rare CNVs when compared to controls. The
overrepresentation of rare genic CNVs in HSCR patients implies
that some CNVs could be pathogenic, regardless of the size and
occurrence.
Rare CNVs distribution in syndromic HSCR and isolated
(non-syndromic) HSCR patients
We have previously demonstrated that the genetic susceptibility
to HSCR varies across sub-phenotypes such as familiality and
segment length [2]. To assess if such genetic heterogeneity also
occurs at the structural variation level, we further examined the
CNV burden for 29 syndromic and 100 non-syndromic (isolated)
HSCR separately.
As illustrated in Figure 1, syndromic HSCR cases, on average,
harbored longer CNVs than non-syndromic HSCR cases or
controls (p=1.5061025 vs. controls) even when the 8 HSCR
patients with Down syndrome were excluded from the analysis.
Had these patients been taken into account, the significance of the
association would have been much lower (p,161028). On the
other hand, non-syndromic HSCR cases were enriched with rare
CNVs compared to syndromic patients or controls (p=4.0061026
vs. controls). Whilst the involvement of CNVs is somewhat
Author Summary
Copy number variations (CNVs) are significant genetic risk
factors in disease pathogenesis and represent an impor-
tant portion of missing heritability for some human
diseases, making their discovery essential for the identifi-
cation of genes and risk factors for a wide range of
diseases, including Hirschsprung disease (HSCR, congenital
colon aganglionosis). Since the discovery of the major
HSCR gene, RET, a number of rare mutations have been
reported in RET and other genes involved in the
development of the enteric nervous system. However,
these mutations contribute to only a small proportion of
the disease susceptibility. Taking advantage of the recent
technical and methodological advances, we have exam-
ined the contribution of CNVs to the disease. We have
found that HSCR patients are enriched with CNVs
encompassing genes. In particular, we found that dele-
tions of NRG3, a paralog of the previously identified HSCR–
susceptibility gene NRG1, were associated with the HSCR
phenotype.
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expected in syndromic patients, the excess of rare CNVs in
isolated HSCR, irrespective of the size, suggested that copy
number variants also contribute to the manifestation of isolated
Hirschsprung disease.
It is tempting to speculate that the CNVs present in non-
syndromic HSCR patients may contribute to the phenotype by
affecting the regulation or gene-dosage of genes members of those
biological pathways involved in the development of the enteric
nervous system. Such variations could add up to the phenotypic
expression of HSCR. On the other hand, the presence of longer
CNVs in syndromic HSCR implies a larger number of disrupted
genes, and consequently, a larger number of systems may be
affected during developmental stages. Given that the increase in
CNV rate was not evident in syndromic HSCR, long CNVs
disrupting multiple genes are likely to have a more deleterious
effect. One of these genes is likely to implicate in the development
of enteric nervous system, particularly the etiology of Hirschsprung
disease.
No differences in CNV rate or type were observed when
patients were stratified according to the length of the aganglionic
segment.
CNV analysis of syndromic HSCR patients reveals putative
candidate genes
Among the 7 large CNVs (.1 Mb) discovered in HSCR
patients (Table 2), four were found in unrelated syndromic HSCR
patients with mental disabilities (Table 2, in bold). It is interesting
to note that three CNVs—a 29 Mb deletion in 11q14.2-q23.2, a
16.68 Mb deletion in 13q21.31-q22.3 and an 11 Mb duplication
in 16p11.2-p12.3—coincide with the recently identified candidate
regions for intellectual disability (ID) [6,13–15]. In addition, the
patient carrying the 16p duplication had also been diagnosed with
epilepsy and, incidentally, this 16p11.2 region had also been
reported as an epilepsy-implicating loci [16,17]. While intellectual
disability and Hirschsprung disease are frequently associated, it is
highly probable that these overlapping regions encompass genes
that contribute to the etiology and hence explain the comorbidity
of both disorders.
We subsequently examined these regions on other non-
syndromic patients, which further revealed 4 smaller deletions
encompassed by the 11q14.2-q23.2 CNV. Altogether, several
genes were recurrently and uniquely covered by CNVs in patients,
Table 1. Global CNV burden in HSCR patients.
Size (kb) CNV burden (Rate)a CNV burden (Gene count)
Baselineb Ratioc P
Conditional
Pd Baseline Ratio P
Conditional
P Baseline Ratio P
Conditional
P
All CNVs
Frequency
Common 141.3 0.72 0.025* 0.98 2.33 0.96 0.61 0.59 2.74 0.90 0.62
Rare 135.0 2.89 4.6161023** 1.0361023** 2.27 1.97 1.5061025*** 4.9761023** 1.80 4.13 6.0061026*** 1.3061025***
Rare CNVs
Size
Alle
Del 82.2 4.57 0.021* 6.2761023** 1.22 2.31 9.2061025*** 0.017* 0.54 7.61 5.0061026*** 2.6061025***
Dup 179.9 1.51 0.086 0.030* 1.05 1.57 0.019* 0.074 1.26 2.65 8.5361023** 0.015*
Long (.100 kb)
Del+Dup 338.6 3.05 0.013* 2.5161023* 0.69 1.44 6.7761023** 0.020* 1.12 5.01 1.1161024** 7.3061025***
Del 286.5 6.54 0.047* 0.015* 0.22 1.78 0.014* 0.051 0.21 14.23 4.2561024** 2.6161024**
Dup 351.3 1.39 0.12 0.044 0.47 1.27 0.16 0.11 0.92 2.95 0.021* 0.023*
Rare CNVs
Occurence
Singleton
Del+Dup 148.2 3.53 3.7161023** 8.7861024** 1.34 2.33 4.3061025*** 7.3861023** 1.26 5.35 1.1061025*** 4.1061025***
Del 84.9 7.19 0.019* 4.7561023** 0.76 2.51 5.7361024** 0.042* 0.38 9.88 3.9061025*** 8.9061025***
Dup 220.2 1.58 0.081 0.041 0.57 2.11 5.2261023** 0.029* 0.88 3.42 6.3561023** 0.014*
2–4 times
Del+Dup 114.9 5.28 0.025* 9.9761023** 0.97 1.42 2.9161023** 0.052 0.60 4.24 5.9461023** 1.6661023**
Del 79.3 7.95 0.14 0.050 0.47 1.97 2.9061024** 0.017* 0.17 9.75 8.3061024** 9.3461024**
Dup 143.6 2.23 0.18 0.14 0.50 0.92 0.72 0.68 0.44 2.14 0.23 0.17
aRate: number of CNVs per individual.
bBaseline: size, rate or gene count of controls.
cRatio: Case/control ratio.
dP-value for conditional permutation based on score of LRR_SD, BAF_drift and median absolute deviation.
eDel+Dup of all rare CNVs was specified as above.
*0.01,p,0.05;
**1024,p,0.01;
***p,1024.
doi:10.1371/journal.pgen.1002687.t001
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including dynein, cytoplasmic 2, heavy chain 1 (DYNC2H1) and
contactin 5 (CNTN5). DYNC1H1 encodes a cytoplasmic dynein
implicated in axonal transport and retrograde trafficking. Muta-
tions in DYNC2H1 were reported to be associated not only with ID
[18] but also with abnormal skeletogenesis which is occasionally
found in HSCR [19,20]. Recent studies in mice also showed that
Dync2h1 mutations disrupted sonic hedgehog (Shh) dependent
neural patterning and, most importantly, Shh is essential in
gastrointestinal development, plausibly by regulating enteric
neural crest cells migration [21–24]. Contactin 5, also known as
NB-2, is a paralog of DSCAM and L1CAM both previously
implicated in HSCR [25–28]. All three genes encode neural cell
adhesion molecules belonging to the same immunoglobin super-
family. CNTN5, together with its paralogs, is involved in the
nervous system. It mediates cell surface interactions and the
formation of axon connections [29,30].
Interestingly, the 13q deletion was found to encompass the
second major HSCR gene—EDNRB. Screening among non-
syndromic patients revealed an additional 44 kb deletion disrupt-
ing the first exon and intron of EDNRB.
Apart from EDNRB, none of the other HSCR genes were found
to overlap or encompass any copy number changes even if all
patients were considered. This result is in line with the negative
findings of previous studies on structural variations intersecting
selected HSCR-genes [9,10]. As for other chromosomal regions
known to segregate with HSCR (3p21 [31,32], 19q12, 4q31-q32
[33] and 9q31 [34,35]), only 2 rare genic CNVs were observed
(Table S4). Neither CNV appeared functionally related to the
nervous system development nor to the differentiation or
migration of neural crest cells. Likewise, no significant overrep-
resentation of CNVs was found on chromosome 21 [8]. We also
investigated chromosomal regions reported altered in HSCR
patients as described by the HSCR consortium, including trisomy
21, 10q11 and 13q22 deletions [1]. We found 11 HSCR-specific
CNVs intersecting those implicated regions and in particular, 2
CNVs mapped within 10q11 and 3 within 13q22 where RET and
Figure 1. CNV burden for syndromic (Syn) and non-syndromic (Non-syn) HSCR patients relative to controls (Ctrl). The burden was
measured with reference to the (A) size, (B) rate and (C) gene count of CNVs. Red and blue bars denote the mean value of the corresponding test for
deletion and duplication respectively. Summary statistics as well as conditional permutation p-value was shown in (D).
doi:10.1371/journal.pgen.1002687.g001
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EDNRB reside respectively (Table S5). However, none of the
10q11 deletions encompassed RET. Further investigation of the 6
remaining genic CNVs gene(s) is warranted as it may lead to the
discovery of new HSCR-susceptibility genes.
Other genic CNVs
Taken together, a total of 237 non-redundant, rare genic copy
number variable regions (CNVRs) were exclusively observed in
HSCR patients, corresponding to 246 unique structural variants
(see Text S1). To confirm their uniqueness, we compared our
HSCR-specific CNVs with the recently published CNV profile on
Asian populations [36]. Only two CNVRs were observed in other
Asians (Korean or Japanese) and, most importantly, none were
observed in the Chinese population. A catalog of these HSCR-
specific CNVRs together with the overlapping genes is provided in
Table S5. Specially, additional paralogs of CNTN5, including
CNTN4, SDK1, DSCAML1, ROBO3 and ROBO4 were disrupted by
HSCR-specific CNVs, highlighting the potential relevance of this
immunoglobin family in the development of the disease.
NRG3 deletion
We further explored if any particular CNV might be disease
causative by comparing the relative frequency in cases to controls. A
significant association was found for a CNVR mapping to intron 1
of neuregulin 3 (NRG3) located on 10q23.1 (HSCR-CNVR129.1,
chr10:84,034,612–84,048,907; hg18; p=1.6461023). Five hemizy-
gous deletions (3.88%), with estimated length ranging from 8 to
14 kb, were observed in patients (2 syndromic and 3 isolated HSCR
patients) while none of the controls had such deletion (Figure 2A).
Despite its absence in the controls, it is not a novel CNV. It overlaps
with 2 deletions (ID:2882 & 48644) reported for normal population
according to the Database of Genomic Variants (DGV, Figure 2B).
The former one, with similar boundaries as our cases, has been
observed in one HapMap Han Chinese from Beijing (CHB) [37]. A
much lower frequency (0.1%) was observed for the latter CNV
which extends further upstream [38]. Even though the NRG3
deletion may not be deleterious, its ten-fold increase in rate for
HSCR patients is highly suggestive of pathogenicity. Intriguingly,
the deletion encompasses region marked by strong enhancer
chromatin signature (H3K4me1) and DNaseI hypersensitivity,
raising the possibility that it might be directly functional (Figure
S7) [39].
Neuregulin 3, again, is a paralog of a HSCR-associated gene—
neuregulin 1 (NRG1; 8p12)—previously discovered in our genome-
wide association study utilizing the same intensity data. It encodes
a ligand which physically interacts with a transmembrane tyrosine
kinase receptor, ErbB4. NRG3, through activating ErbB4, influ-
ences neuroblast proliferation, migration and differentiation [40].
Its paralog, NRG1, in addition to ErbB4 also binds to ErbB2 and
ErbB3. Meanwhile, a 35 kb ErbB4 deletion (HSCR-CNVR32.1,
chr2:212,872,711–212,889,560) was also observed uniquely in a
syndromic HSCR patient.
Due to the biological relevance of NRG3 in HSCR, we used
real-time qPCR to experimentally confirm the deletions. A
random set of 46 patients called with normal copy number was
chosen for validation. We successfully validated the copy number
states of all these samples as shown in Figure 2C. Next, we
attempted to replicate this finding on an independent set of 96
cases and 220 controls (Figure 2D). In addition to the 5 deletions
found in the discovery phase, nine more deletions (9.38%) were
detected in cases while 5 were identified in controls (2.27%)
(p=6.9261023). Seven of those deletions were found in isolated
HSCR patients. In addition, real-time qPCR detected 2 novel
duplications (2.08%) among the patients included in the replica-
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tion phase (one patient affected with isolated HSCR and one with
HSCR-Meckel diverticulum). All CNVs detected were verified by
an additional TaqMan probe. Dissection of sample origin, i.e.,
from North or South of China, is detailed in Table S6. We found
no evidence of association between sample origin and NRG3
deletion for both cases (p=0.17) and controls (Fisher exact test
p=1). To assess if the CNVs are de novo, parent-child transmission
analysis was performed for those probands (n = 5; 3 with deletion
and 2 with duplication) for whom parental DNA was available
(Figure 2E). All 3 deletions tested were found to be inherited from
normal parents. However, the duplication could not be detected in
the parents. Considering deletions alone, we combined association
results of both phases, yielding a strong association between
HSCR and NRG3 (p=3.3661025; p=7.7661026 when consid-
ering all NRG3 deletions and duplications). Such a 7 fold (6.28% in
cases and 0.91% in controls) enrichment of deletions together with
de novo duplications strongly suggested NRG3 as a candidate HSCR
gene.
Given that most NRG3 deletions are inherited, we next
attempted to define their nature, i.e. whether they represent a
collection of distinct mutations or a low frequency copy number
polymorphism instead. In particular, we tried to address two
questions, (1) are the deletions on the same haplotype background
and if so, (2) do they represent a common ancestral mutation. To
achieve this, we performed haplotype analysis on the 206 kb
region (chr10:83,990,316–84,195,982) where all 5 typed patients
with deletion identified through the GWAS shared at least one
allele (i.e. identity-by-state of at least 1). Phasing by BEAGLE
revealed a 4-SNP common haplotype harboring the deletion (from
rs7085458 to rs7897939; chr10:83,990,316–84,063,139), which
suggested a 73 kb identity-by-descent (IBD) segment (Tables S7
and S8). Indeed, this 4-SNP haplotype is the best tagging genetic
variant for the deletion, which had a moderate significance of
association in our original GWAS data (p=0.005). Identification
of the CNV breakpoint (Text S1, Figure S8 and Table S9)
revealed a deletion of 19,652 bp in length shared by those 5
patients sharing the haplotype. Close inspection of the boundary
sequence, revealed a 4 bp homology between the 59 and 39 ends of
the deletion. Such microhomologies are observed in 70% of the
deletion breakpoints and may reflect the mutational mechanisms
leading to the formation of a CNV [41]. These analyses therefore
suggest that this deletion involving NRG3 is a low frequency copy
number polymorphism (Figure 2F).
Discussion
Current data indicates that sporadic HSCR phenotype may
result from the interplay and/or accumulation of both common
and rare functional DNA variants in genes involved in the enteric
nervous system development. These variants may also include
structural variations, yet the contribution of CNVs to HSCR had
never been investigated at genome-wide level, presumably,
because many CNVs are submicroscopic, thus undetectable by
conventional karyotyping techniques.
Here we present the first comprehensive survey of copy number
variations in HSCR and provide a catalog of rare genic CNVRs
possibly implicated in the manifestation of the Hirschsprung
disease phenotype. Structural variants identified here are individ-
ually rare but collectively common in HSCR patients.
One of the major challenges in CNV discovery is to
discriminate between benign and pathological variants. The rarer
or longer the CNV, the more likely it is to be pathogenic. Also, the
involvement of a gene that lies within a pathway known to contain
genes associated with a similar phenotype strengthens the
possibility of pathogenicity. Indeed, the CNVs reported here meet
the above criteria as we found a plethora of rare CNVs in HSCR
patients, in terms of both rate and gene count. In addition,
syndromic-HSCR patients were enriched in longer CNV and a
number of HSCR-specific CNVs overlapped with paralogs of
previously HSCR-implicated genes were observed.
Meanwhile, for rare CNVs, the significant increase in size in
syndromic HSCR as well as the overload in number in non-
syndromic HSCR suggested a correlation between pathogenesis
and genetic heterogeneity at structural level. We attempted to
address such correlation across other sub-phenotypes, such as
gender and length of aganglionosis. Nonetheless, our study design
of random ascertainment limited the sample size of the minor
groups and consequently did not permit a detailed investigation of
the CNV contribution.
Neuregulin 3 (NRG3) encodes a protein similar to its paralog
NRG1 and both play important roles in the developing nervous
system. As seen with other pathologies, including autism and
schizophrenia, several members of a given protein family may
associate with the same phenotype, individually or together [7].
Thus far the genes involved in HSCR belong to the two major
signaling pathways (RET and EDNRB). The current finding on
NRG3 and ErbB4 together with our previous study have
established the contribution of a new protein family—NRGs—to
the disease. Although we have confirmed that both rare and
common variants of NRG1 are associated with HSCR [3,42], the
molecular properties and mechanisms leading to the disease
remains unclear. As both NRG1 and NRG3 share the same
receptor, they may work synergistically or antagonically [43].
Importantly, rare and common variants in NRGs and their
receptors have been implicated in schizophrenia [44–52].
Furthermore, rare deletions of NRG1, NRG3 and ErbB4 were
described in schizophrenic patients as well [44,53,54]. The
association of these genes with two different disorders in the
nervous system not only emphasizes the relevance of NRGs in the
nervous system but also strengthens the validity of the findings.
Based on the inheritance we observed, we proposed a two-hit
hypothesis for the deletion where the ‘‘second hit’’ could be a
mutation or copy number variant in NRG or other inter-related
pathways, which explained the incomplete penetrance in parents
[55].
One of the intriguing observations from this study is the genetic
overlap between Hirschsprung disease and schizophrenia. In
addition to the pleiotropic effect of neuregulins and ErbB families,
the major HSCR gene, RET, was found deleted exclusively in
schizophrenia patients in a recent genome-wide CNV analysis
[15]. Interestingly, this report, together with Wang et al. (2010),
also suggested an association between our candidate genes CNTN5
Figure 2. NRG3 deletions identified in HSCR patients. (A) Intensity signals of 5 HSCR patients (CN= 1; red) with NRG3 deletions together with
other samples of normal copy number (CN= 2; grey). Deleted regions are shown by the dark red bar and are highlighted in pink. (B) Consensus CNV
segments of the 5 NRG3 deletions (red) and the overlapping DGV segments (blue; with DGV ID). (C, D and E) Box plot of NRG3 copy number estimates
by real-time PCR. Samples were grouped according to the called copy number states (CN= 1, red; CN= 2, white; CN=3, blue); (C) Validation of 5
deletions (CN=1) and 24 copy-neutral (CN=2) HSCR patients in the discovery phase; (D) Follow-up analysis on independent case-controls set and (E)
Transmission analysis for probands with NRG3 deletions (child CN= 1) or duplications (child CN= 3). (F) Sequence of the NRG3 deletion boundary
region showing the breakpoint (upstream boundary chr10: 84032610; downstream boundary chr10: 84052262).
doi:10.1371/journal.pgen.1002687.g002
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and schizophrenia [56]. CNTNAP2, which was recurrently and
exclusively deleted in HSCR cases, was also associated with
multiple neurodevelopmental and neuropsychiatric disorders [57–
59]. It is thus tempting to speculate that pathogenic alterations
affecting common pathway(s) may act in the development of both
diseases. Such hypothesis is further supported by the frequently
observed association of intestinal dysmotility with psychiatric
disorders [60–62]. Further investigation into the suggestive genetic
link is required. By understanding the pleiotropy and the
intersecting pathway(s), one can optimize the search for other
causal variants underlying HSCR.
Despite none of the known HSCR genes other than EDNRB nor
HSCR-implicated regions was deleted or duplicated in our
analysis, the observation did not elude the presence of structural
variations affecting these genes. Rather, it suggested that the rare
deletions observed previously, like rare mutations for HSCR
patients, might not be a global phenomenon but segregate within
individual families.
Similarly, we did not find evidence of global contribution of
copy number polymorphisms (CNPs) to HSCR in this study. It
could be that indeed these common CNVs are not implicated on
the manifestation of the phenotype or that our observation results
from the limitations posed by the early genotyping platforms. Our
data was generated by Affymetrix 500K, well known to suffer from
relatively low SNP density and no CNV probes. Regions with
CNPs are more likely to violate Hardy-Weinberg equilibrium and
could be preferentially excluded from SNP genotyping. Conse-
quently, the power to detect short and/or common CNVs is
limited. It should be noted that our stringent quality control to
maximize false positive findings in scarify of false negatives also
added a further complication to the interpretation of the role of
CNPs in HSCR. These limitations applied also to the discovery of
the NRG3 deletions. The higher frequency of copy number
changes in the replication samples might only reflect the lower
power to detect shorter CNVs with high confidence in the
discovery phase.
To conclude, our study provides not only a catalog of rare genic
HSCR CNVs but also valuable insights into the contribution of
rare CNVs in the phenotypic heterogeneity of HSCR. Our finding
illuminates the potential of discovering new HSCR genes and
provides grounds for further investigation of the role of NRG
family in the disease mechanisms.
Materials and Methods
Samples
Discovery phase. We started with 173 HSCR Chinese
sporadic probands and 340 controls passing SNP-based quality
control (QC) as described previously (see Text S1) [3,35]. All
HSCR patients had been screened for the main HSCR genes,
namely RET, NRG1, EDNRB, EDN3 and GDNF. Samples were
genotyped using Affymetrix GeneChip 500K array in which ,500,000
SNP probes were interrogated separately on two chips (Nsp and
Sty). Further characteristics of the patients can be found in Table
S1 and in Garcia-Barcelo et al. (2009) and Tang et al. (2010) [3,35].
Only autosomal SNPs were considered in the CNV analysis.
After pre- and post-CNV calling QCs, 129 HSCR cases and
331 controls were left, 29 of whom have additional congenital
anomalies in conjunction with Hirschsprung disease. Among
these, 8 patients have Down’s syndrome and an additional 6
patients with intellectual disability. Details regarding the associated
anomalies and known CDS mutations in HSCR genes were listed
in Table S2. Out of these 129 patients passing QC, parental DNA
was available for 46 probands.
The study was approved by the institutional review board of
The University of Hong Kong together with the Hospital
Authority (IRB: UW 06-349 T/1374).
Replication phase. To replicate our finding on NRG3
deletion, an independent set of 96 Chinese HSCR cases and
220 controls were subject to the genomic DNA quantification
using quantitative real-time PCR. We further determined the
inheritance pattern of each NRG3 CNV discovered (n= 5) for
which parental DNA was available.
CNV calling and quality control (QC)
The overview of CNV calling as well as quality control was
summarized in Figure S1 and was detailed in Text S1. Briefly, pre-
calling QCs were carried out to remove samples showing relatively
low quality in SNP genotyping and samples prone to bias in CNV
calling were excluded [63]. Next, CNVs were called by two
programs, PennCNV [64] and Birdsuite [65], and were then
filtered for abnormal calls. In order to obtain a high-quality CNV
dataset, we restricted our analysis to consensus CNV segments
consistently called by both programs (Figure S5). Finally, a total of
866 and 1515 CNVs passing quality controls in 129 cases and 331
controls respectively were used for CNV analysis.
CNV analysis
Global CNV burden analysis. CNVs were defined as rare if
their frequencies were ,1% in the total sample (cases and
controls) and were otherwise considered as common. Tests of
CNV burden (1-sided) in terms of size, number of CNV segments
and number of genes overlapped were performed using permu-
tation by PLINK [66]. Gene annotation was based on UCSC
RefSeq (hg18) and NCBI Build 36 was used throughout the study.
We defined genic CNVRs as those with more than 1 bp
overlapped with any genic region (from 210 kb upstream of the
transcription start site to +10 kb downstream).
CNV analysis on HSCR gene and HSCR–implicated
regions. Four HSCR-implicated regions (3p21 [31,32], 19q12,
4q31-q32 [33], 9q31 [34,35]) and 12 HSCR genes (RET, GDNF,
NRTN, SOX10, EDNRB, EDN3, ECE1, ZFHX1B, PHOX2B, TCF4,
KIAA1279 and NRG1) [1] were evaluated for the presence of rare
CNVs.
Association analysis. Copy number variable regions
(CNVRs) were defined as described in Conrad et al. (2009) [67]
and in Text S1. Two-sided Fisher’s exact test was used to test for
association between NRG3 deletions and Hirschsprung disease,
both for the discovery and subsequent replication phases. To
combine the association results, meta-analysis was performed by
pooling the p-values while weighted by the sample sizes of each
phase.
Haplotype analysis on the NRG3 deletion
We phased the genotype calls (1 Mb upstream and downstream)
of all 129 HSCR cases and 331 controls using BEAGLE [68,69].
To increase accuracy (as phasing a small sample set may be
somehow inaccurate), we included the unphased genotypes of the
3 carrier parents (from whom NRG3 deletions were inherited) and
phased genotypes of 193 Asians (HG00578 was removed due to
relatedness) from the 1000 Genomes Project as reference panel
[70]. SNPs within the deleted region were recorded as a single bi-
allelic marker, with deletion and non-deletion as the two alleles.
Association between HSCR and the 4-SNP haplotype encom-
passing NRG3 deletion was performed in PLINK.
NRG3 deletion validation and replication. Copy number
validation and replication was performed by quantitative real-
time PCR (ABI Prism 7900 Sequence Detection System; Applied
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Biosystems) using TaqMan Copy Number Assay. The assay was
carried out in quadruplicates with the TaqMan Copy Number
Reference Assay according to the manufacturer’s protocol. The
reference assay targets a copy-number neural region of RNaseP
gene, serving as an internal standard. To achieve high
confidence, copy number changes for replication samples were
detected and verified by 2 NRG3 probes (Hs03732951_cn,
chr10:84,043,528 & Hs03749105_cn, chr10:84,045,098) which
fall within the 4 kb minimal overlapping region of the NRG3
deletions (chr10: 84,041,355–84,045,997). Relative levels of
NRG3 to reference probes were determined using comparative
CT method. In brief, the mean differences in cycle threshold (CT)
DCT between the NRG3 and the reference probes for all
replicates were computed and were subsequently normalized
for copy number prediction.
Supporting Information
Figure S1 Flowchart of CNV discovery and analyses for
Hirschsprung disease. Empty boxes indicate number of individuals
surviving each step of quality control (QC) while filled boxes
designate the procedures for CNV-level discovery and filtering.
Hollow arrows denote the CNV exclusion criteria.
(TIF)
Figure S2 PCA plot of normalized intensities in log R ratio
(LRR) for the two 500K chips (Nsp and Sty). The first and second
principal components were plotted for (A) by-plate and (B) by-
cluster normalized intensities. Batches were represented in
gradients of red and blue for HSCR cases and controls
respectively.
(TIF)
Figure S3 Box plot of intensity variation parameters for
PennCNV. (A) log R ratio variation (LRR SD); (B) BAF drift;
(C) median absolute deviation (MAD) and (D) wave factor.
Statistical significance between cases and controls was assessed by
rank sum test.
(TIF)
Figure S4 Box plot of intensity variation parameters for
Birdsuite. (A) copy number (CN) estimate and (B) variation in
intensity per chromosome.
(TIF)
Figure S5 Schematic diagram defining the consensus CNV
segments. Green and red boxes denote the segments called by
Birdseye and PennCNV respectively while consensus CNV was
represented by grey shaded box.
(TIF)
Figure S6 Violin plot of CNV rate and gene count for HSCR
cases and controls. Shaded regions of the violin plots represent the
frequency distribution of CNV rate (upper panel) and gene count
(lower panel) for (A,D) all CNVs, (B,E) rare and (C,F) common
CNVs. The box in the middle resembles the standard box plot,
depicting the lower quartile, median and upper quartile. Samples
with more than 30 CNVs (n = 4) are not shown to better illustrate
the distribution of the majority.
(TIF)
Figure S7 Functional characteristics at NRG3 deletion. Enhanc-
er regions implicated by strong signals of chromatin modification
H3K4me1 and DNaseI hypersensitivity were shown using
corresponding ENCODE tracks in the UCSC genome browser
(hg18).
(TIF)
Figure S8 Detection of the NRG3 deletion breakpoints. Semi-
quantitative PCR reactions (Pr1 to Pr8) designed across a 27 kb
region spanning the predicted NRG3 deletion (red vertical stripes
on white background) and boundary regions (upstream: green
background; downstream: purple background). Pr 4 primer pair
was specifically designed within the deletion and used as ‘‘deletion-
control’’. Blue lines: DNA with predicted NRG3 deletion used as
template; yellow lines: DNA with no deletion predicted used as
template. Primer pair Pr SeqF and PrSeqR was used to amplify
the breakpoint once the NRG3 boundaries had been refined by
the PCR reactions described. (B): PCR products (1,211 bp)
obtained with Pr SeqF and PrSeqR on DNA template from
HSCR patients and parents predicted to harbor the NRG3
deletion and from individuals without deletion (1: Patient HK7, 2:
HK7 maternal DNA, 3: Patient HD12, 4: HD12 paternal DNA,
5: Patient HK81, 6: HK81 paternal DNA, 7: Patient HK107; 8:
Patient HK122, 9: Individual with no predicted deletion, 10:
Individual with no predicted deletion). C: negative control (H2O
as template). *Denotes amplification with primer pair Pr4 which
was used to ensure both DNA quality and PCR efficiency
(1,024 bp) on the samples tested. M: 1 kb marker (GeneRuler).
(TIF)
Table S1 Characteristics of the HSCR patients included in the
CNV discovery and replication phases.
(DOCX)
Table S2 Genic-CNV and coding sequence (CDS) mutation
profile of HSCR syndromic patients.
(DOCX)
Table S3 Relationship between number and length of CNVs
(DOCX)
Table S4 CNVs overlapping HSCR-implicated regions.
(DOCX)
Table S5 List of rare, HSCR-specific genic CNVs.
(XLS)
Table S6 Summary of sample origin for the discovery and
replication phase
(DOCX)
Table S7 Haplotypes harbouring NRG3 deletion for the 5
carriers of the discovery phase.
(DOCX)
Table S8 SNP information of IBS segment shared by 5 HSCR
patients with NRG3 deletions corresponding to Table S7.
(DOCX)
Table S9 Primers and PCR conditions used in the detection of
the deletion breakpoint.
(DOCX)
Text S1 Genome-wide copy number analysis uncovers a new
HSCR gene: NRG3.
(DOCX)
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